Hui Dai

1.5k citations
38 papers · 1.2k indexed · 1 hit paper · h-index 16
Topics
Glycosylation and Glycoproteins Research (8 papers)Polysaccharides and Plant Cell Walls (8 papers)Immune Cell Function and Interaction (6 papers)
Partner nations
ChinaHong KongRomania

In The Last Decade

Hui Dai

36 papers receiving 1.2k citations

Hit Papers

Naringenin attenuates non‐alcoholic fatty liver disease b...2019202620212023201950100150200

Peers

Hui Dai
Comparison fields: 5 of 102
  • Molecular Biology 472
  • Plant Science 343
  • Immunology 289
  • Pharmacology 200
  • Complementary and alternative medicine 175
Replace Yixi Bao with:
Yixi Bao China
Xia Luo China
Lian Zhou China
Jie‐Young Song South Korea
Se Eun Byeon South Korea
Ran Duan China
Shuang Luo China
Yeon‐Sook Yun South Korea
Hyung Sook Kim South Korea
Hui Dai relative to Yixi Bao China Yixi Bao's profile →
Citations per field
00.5×1.5×
Yixi Bao · 1×
Citations per year

Countries citing papers authored by Hui Dai

Since Specialization
Citations

This map shows the geographic impact of Hui Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Dai more than expected).

Fields of papers citing papers by Hui Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Dai. The network helps show where Hui Dai may publish in the future.

Co-authorship network of co-authors of Hui Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Dai. A scholar is included among the top collaborators of Hui Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Dai. Hui Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 17
5 9
6 11
7 8
8 17
9 21
10 20
11 43
12 19
13
Research review and prospect of Hosta species.
1
14 1
15 6
16 3
17 12
18 15
19 2
20 341

About Hui Dai

Hui Dai is a scholar working on Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (8 papers), Polysaccharides and Plant Cell Walls (8 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Complementary and alternative medicine (175 citations), Pharmacology (138 citations) and Immunology (289 citations). Hui Dai has collaborated with scholars based in China, Hong Kong and Romania. Frequent co-authors include Xiao‐Ming Gao, Baomei Shao, Zhongjun Li, Pengfei Tu, Wen Xu, Xiangmei Wu, Pengfei Tu, Zhibin Lin, Wen Xu and Jiawei Xie. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026